SOPHiA GENETICS (SOPH) EV to EBITDA (2021 - 2026)

SOPHiA GENETICS has disclosed EV to EBITDA across 6 years of filings, most recently posting 14.34 for Q2 2026.

• In Q2 2026, EV to EBITDA fell 136.91% year-over-year to 14.34; the TTM figure through Jun 2026 stood at 3.9 (down 105.43% YoY), while the FY2025 annual figure was 2.29, down 156.48% from the prior year.
• EV to EBITDA came in at 14.34 for Q2 2026 at SOPHiA GENETICS, up from 15.83 in the prior quarter.
• In the past five years, EV to EBITDA ranged from a high of 3.07 in Q4 2022 to a low of 15.83 in Q1 2026.
• Average EV to EBITDA over 5 years is 7.38, with a median of 8.46 recorded in 2025.
• Year-over-year, EV to EBITDA surged 110.15% in 2022 and slumped 1049.03% in 2023.
• Over 5 years, EV to EBITDA stood at 3.07 in 2022, then tumbled by 222.83% to 3.77 in 2023, then fell by 5.05% to 3.96 in 2024, then sank by 121.26% to 8.76 in 2025, then sank by 63.61% to 14.34 in 2026.
• Per Business Quant data, the three most recent EV to EBITDA figures were 14.34 in Q2 2026, 15.83 in Q1 2026, and 8.76 in Q4 2025.